NL7811220A - Cefalosporanzuurderivaten, werkwijzen voor de bereiding daarvan, farmaceutische preparaten. - Google Patents
Cefalosporanzuurderivaten, werkwijzen voor de bereiding daarvan, farmaceutische preparaten.Info
- Publication number
- NL7811220A NL7811220A NL7811220A NL7811220A NL7811220A NL 7811220 A NL7811220 A NL 7811220A NL 7811220 A NL7811220 A NL 7811220A NL 7811220 A NL7811220 A NL 7811220A NL 7811220 A NL7811220 A NL 7811220A
- Authority
- NL
- Netherlands
- Prior art keywords
- preparation
- methods
- acid derivatives
- pharmaceutical preparations
- cephalosporanic acid
- Prior art date
Links
- YGBFLZPYDUKSPT-MRVPVSSYSA-N cephalosporanic acid Chemical class S1CC(COC(=O)C)=C(C(O)=O)N2C(=O)C[C@H]21 YGBFLZPYDUKSPT-MRVPVSSYSA-N 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB4735277 | 1977-11-14 | ||
| GB1681078 | 1978-04-27 | ||
| GB7835436 | 1978-09-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL7811220A true NL7811220A (nl) | 1979-05-16 |
Family
ID=27257420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL7811220A NL7811220A (nl) | 1977-11-14 | 1978-11-13 | Cefalosporanzuurderivaten, werkwijzen voor de bereiding daarvan, farmaceutische preparaten. |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US4267176A (fr) |
| JP (1) | JPS5492987A (fr) |
| AT (1) | AT369005B (fr) |
| AU (1) | AU523346B2 (fr) |
| CA (1) | CA1120923A (fr) |
| CH (1) | CH645904A5 (fr) |
| DE (1) | DE2848912A1 (fr) |
| DK (1) | DK502078A (fr) |
| ES (5) | ES475035A1 (fr) |
| FR (2) | FR2411839B1 (fr) |
| GB (1) | GB2010840B (fr) |
| HU (2) | HU182098B (fr) |
| IT (1) | IT1192287B (fr) |
| NL (1) | NL7811220A (fr) |
| SE (2) | SE7811637L (fr) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1192287B (it) * | 1977-11-14 | 1988-03-31 | Fujisawa Pharmaceutical Co | Derivati di acido cefalosporanico ad azione farmaceutica e relativo procedimento di preparazione |
| DE2818263A1 (de) * | 1978-04-26 | 1979-11-08 | Bayer Ag | Beta-lactamantibiotika |
| US4409214A (en) * | 1979-11-19 | 1983-10-11 | Fujisawa Pharmaceutical, Co., Ltd. | 7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof |
| JPS5716886A (en) * | 1980-07-04 | 1982-01-28 | Fujisawa Pharmaceut Co Ltd | Azetidinone bearing oxo group or its salt or hydrate and their preparation |
| EP0156118A1 (fr) * | 1980-08-29 | 1985-10-02 | Fujisawa Pharmaceutical Co., Ltd. | Produits de départ pour la préparation de composés céphem et procédés pour leur préparation |
| US4577014A (en) * | 1981-09-08 | 1986-03-18 | Eli Lilly And Company | Thieno and furopyridinium-substituted cephalosporins |
| US4402955A (en) * | 1981-10-02 | 1983-09-06 | Eli Lilly And Company | Dioximino cephalosporin antibiotics |
| US4379787A (en) * | 1981-10-02 | 1983-04-12 | Eli Lilly And Company | Oximino-substituted cephalosporin compounds |
| US4450270A (en) * | 1981-10-02 | 1984-05-22 | Eli Lilly And Company | Dioximino cephalosporin antibiotics |
| US4501739A (en) * | 1982-01-19 | 1985-02-26 | Eli Lilly And Company | Thieno and furopyridinium-substituted cephalosporins |
| US4683227A (en) * | 1985-07-09 | 1987-07-28 | Eli Lilly And Company | Antibiotic derivatives of 7β-[2-(thiazol-4-yl)acetamide]-3-chloro-3-cephem-4-carboxylic acids and compositions and method of use thereof |
| RS52068B (en) | 2005-12-07 | 2012-06-30 | Basilea Pharmaceutica Ag. | USEFUL MANOBACTAM ANTIBIOTICS |
| EA028342B1 (ru) | 2011-09-09 | 2017-11-30 | Мерк Шарп И Доум Корп. | Способы лечения пневмонии |
| US8809314B1 (en) | 2012-09-07 | 2014-08-19 | Cubist Pharmacueticals, Inc. | Cephalosporin compound |
| US8476425B1 (en) | 2012-09-27 | 2013-07-02 | Cubist Pharmaceuticals, Inc. | Tazobactam arginine compositions |
| US9872906B2 (en) | 2013-03-15 | 2018-01-23 | Merck Sharp & Dohme Corp. | Ceftolozane antibiotic compositions |
| US20140274996A1 (en) | 2013-03-15 | 2014-09-18 | Cubist Pharmaceuticals, Inc. | Tazobactam and ceftolozane antibiotic compositions |
| US20140274994A1 (en) | 2013-03-15 | 2014-09-18 | Cubist Pharmaceuticals, Inc. | Stabilizing ceftolozane |
| EP3043797B1 (fr) | 2013-09-09 | 2020-04-08 | Merck Sharp & Dohme Corp. | Traitement d'infections au moyen de ceftolozane/tazobactam chez des sujets ayant une fonction rénale altérée |
| US20150094293A1 (en) | 2013-09-27 | 2015-04-02 | Calixa Therapeutics, Inc. | Solid forms of ceftolozane |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3459746A (en) * | 1965-10-04 | 1969-08-05 | Lilly Co Eli | 7 - heteromonocyclic-substituted acylamido derivatives of desacetyl cephalosporanic acid |
| GB1195203A (en) * | 1966-06-24 | 1970-06-17 | Glaxo Lab Ltd | Cephalosporins |
| CH557381A (de) * | 1967-04-15 | 1974-12-31 | Fujisawa Pharmaceutical Co | Verfahren zur herstellung von (delta)3-cephemverbindungen. |
| CH522677A (de) * | 1969-10-10 | 1972-06-30 | Ciba Geigy Ag | Verfahren zur Herstellung neuer Derivate der 7-Aminocephalosporansäure |
| FR2068419A1 (en) * | 1969-10-27 | 1971-08-27 | Fujisawa Pharmaceutical Co | Antibacterial cephalosporin compsns |
| IE36221B1 (en) * | 1971-04-21 | 1976-09-15 | Ciba Geigy Ag | Acylamino compounds and a process for their manufacture |
| GB1399086A (en) * | 1971-05-14 | 1975-06-25 | Glaxo Lab Ltd | Cephalosporin compounds |
| US3966717A (en) * | 1971-05-14 | 1976-06-29 | Glaxo Laboratories Limited | 7-β-Acylamido-3-carbamoyloxymethylceph-3-em-4-carboxylic acids and salts thereof |
| US4017515A (en) * | 1971-05-14 | 1977-04-12 | Glaxo Laboratories Limited | α-(Etherified oximino) carboxylic acids and acid chlorides |
| US4033950A (en) * | 1971-05-14 | 1977-07-05 | Glaxo Laboratories Limited | 3-Hydroxymethyl-7β-(2-alkoxy-or benzyloxyimino-2-arylacetamido)ceph-3-em-4-carboxylic acids and salts thereof |
| DE2222791A1 (de) * | 1971-05-19 | 1972-12-07 | Ciba Geigy Ag | Neue Pyridinessigsaeurederivate und Verfahren zu ihrer Herstellung |
| BE790287A (fr) * | 1971-10-28 | 1973-04-19 | Delalande Sa | Acides pyrimidin-6yl acethydroxamiques, leur procede de preparation et leur application en therapeutique |
| BE793724A (fr) * | 1972-01-12 | 1973-07-05 | Smith Kline French Lab | Procede de preparation de cephalosphorines non substituees en position 3, nouvelles cephalosporines obtenues et leur utilisation |
| AR208171A1 (es) * | 1972-09-29 | 1976-12-09 | Ciba Geigy Ag | Procedimiento para la obtencion de nuevos derivados del acido cef-3-em-4-carboxilico |
| GB1390141A (en) * | 1973-01-08 | 1975-04-09 | Ici Ltd | Pyrimidine derivatives and processes for their production |
| JPS5932472B2 (ja) * | 1973-03-15 | 1984-08-09 | 藤沢薬品工業株式会社 | ２−アルキル−７−アシルアミノ−２（または３）−セフエム−４−カルボン酸類の製造法 |
| JPS4970990A (fr) * | 1973-09-29 | 1974-07-09 | ||
| US3968109A (en) * | 1973-11-23 | 1976-07-06 | E. R. Squibb & Sons, Inc. | Production of 2-(thio substituted)cephalosporin sulfoxides and 2-(thio substituted)cephalosporins |
| FR2262965A1 (en) * | 1974-03-05 | 1975-10-03 | Delalande Sa | Beta-(4-amino-6-methylpyrimidin-5-yl)propionic acid derivs - with antiulcer, bronchodilator, anticholinergic, hypotensive, diuretic and vasodilator activity |
| US4122259A (en) * | 1974-08-23 | 1978-10-24 | Glaxo Laboratories Limited | 7β-[2-Aryl-2-(etherified oximino)acetamido]-3-N-substituted carbamoyloxymethylceph-3-em-4-carboxylic acids |
| JPS604171B2 (ja) * | 1974-12-05 | 1985-02-01 | 久光製薬株式会社 | 新規な２−アニリノピリジン−３−酢酸誘導体の製造法 |
| DK154939C (da) * | 1974-12-19 | 1989-06-12 | Takeda Chemical Industries Ltd | Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf |
| CA1088049A (fr) * | 1975-06-03 | 1980-10-21 | Takashi Masugi | Procedes d'obtention de derives d'acides alcanamido substitues en 3 et substitues en 7-3-cephem-4 carboxyliques |
| US4152433A (en) * | 1976-03-12 | 1979-05-01 | Fujisawa Pharmaceutical Co., Ltd. | 2-Lower alkyl-7-substituted-2 or 3-cephem-4-carboxylic acid compounds and pharmaceutical compositions |
| US4166115A (en) * | 1976-04-12 | 1979-08-28 | Fujisawa Pharmaceutical Co., Ltd. | Syn 7-oxoimino substituted derivatives of cephalosporanic acid |
| US4104469A (en) * | 1977-04-15 | 1978-08-01 | Bristol-Myers Company | 7-(Syn-α-alkoxy-iminofuryl)acetamido-3-(2-methyl-2,3-dihydro-s-triazolo[4,3-b]pyridazin-3-on-6-ylthiomethyl)-3-cephem-4-carboxylic acids |
| NL7714319A (nl) * | 1976-12-27 | 1978-06-29 | Fujisawa Pharmaceutical Co | Cefalosporineverbindingen en werkwijzen om deze te bereiden. |
| IT1192287B (it) * | 1977-11-14 | 1988-03-31 | Fujisawa Pharmaceutical Co | Derivati di acido cefalosporanico ad azione farmaceutica e relativo procedimento di preparazione |
-
1978
- 1978-11-09 IT IT29653/78A patent/IT1192287B/it active
- 1978-11-10 CA CA000316120A patent/CA1120923A/fr not_active Expired
- 1978-11-10 SE SE7811637A patent/SE7811637L/xx unknown
- 1978-11-10 DK DK502078A patent/DK502078A/da not_active Application Discontinuation
- 1978-11-10 FR FR7831898A patent/FR2411839B1/fr not_active Expired
- 1978-11-10 AT AT0807178A patent/AT369005B/de not_active IP Right Cessation
- 1978-11-10 DE DE19782848912 patent/DE2848912A1/de active Granted
- 1978-11-10 GB GB7843984A patent/GB2010840B/en not_active Expired
- 1978-11-13 HU HU80281A patent/HU182098B/hu unknown
- 1978-11-13 CH CH1166778A patent/CH645904A5/de not_active IP Right Cessation
- 1978-11-13 HU HU78FU368A patent/HU183008B/hu unknown
- 1978-11-13 ES ES475035A patent/ES475035A1/es not_active Expired
- 1978-11-13 NL NL7811220A patent/NL7811220A/xx not_active Application Discontinuation
- 1978-11-13 AU AU41546/78A patent/AU523346B2/en not_active Expired
- 1978-11-14 JP JP14028678A patent/JPS5492987A/ja active Granted
-
1979
- 1979-03-26 FR FR7907572A patent/FR2413369A1/fr active Granted
- 1979-04-24 US US06/032,778 patent/US4267176A/en not_active Expired - Lifetime
- 1979-10-16 ES ES485065A patent/ES485065A1/es not_active Expired
- 1979-10-16 ES ES485066A patent/ES485066A1/es not_active Expired
- 1979-10-16 ES ES485068A patent/ES485068A1/es not_active Expired
- 1979-10-16 ES ES485067A patent/ES485067A1/es not_active Expired
-
1980
- 1980-12-05 US US06/213,684 patent/US4395411A/en not_active Expired - Lifetime
-
1984
- 1984-01-23 SE SE8400332A patent/SE8400332D0/xx not_active Application Discontinuation
-
1985
- 1985-09-19 US US06/777,867 patent/US4596869A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6320832B2 (fr) | 1988-04-30 |
| ES485068A1 (es) | 1980-06-16 |
| DE2848912C2 (fr) | 1990-10-04 |
| CA1120923A (fr) | 1982-03-30 |
| GB2010840B (en) | 1982-12-22 |
| HU182098B (en) | 1983-12-28 |
| US4596869A (en) | 1986-06-24 |
| FR2411839B1 (fr) | 1985-09-27 |
| ES485067A1 (es) | 1980-06-16 |
| FR2413369B1 (fr) | 1984-04-06 |
| CH645904A5 (de) | 1984-10-31 |
| AT369005B (de) | 1982-11-25 |
| FR2411839A1 (fr) | 1979-07-13 |
| SE8400332L (sv) | 1984-01-23 |
| US4395411A (en) | 1983-07-26 |
| ES485066A1 (es) | 1980-06-16 |
| ES485065A1 (es) | 1980-06-16 |
| ATA807178A (de) | 1982-04-15 |
| AU523346B2 (en) | 1982-07-22 |
| SE8400332D0 (sv) | 1984-01-23 |
| HU183008B (en) | 1984-04-28 |
| US4267176A (en) | 1981-05-12 |
| AU4154678A (en) | 1979-05-24 |
| ES475035A1 (es) | 1980-01-01 |
| SE7811637L (sv) | 1979-05-15 |
| DE2848912A1 (de) | 1979-05-17 |
| IT1192287B (it) | 1988-03-31 |
| FR2413369A1 (fr) | 1979-07-27 |
| DK502078A (da) | 1979-05-15 |
| JPS5492987A (en) | 1979-07-23 |
| GB2010840A (en) | 1979-07-04 |
| IT7829653A0 (it) | 1978-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL7811220A (nl) | Cefalosporanzuurderivaten, werkwijzen voor de bereiding daarvan, farmaceutische preparaten. | |
| NL930112I2 (nl) | Benzazepine-2-onen, werkwijzen ter bereiding daarvan, farmaceutische preparaten die deze verbindingen bevatten, alsmede de verbindingen voor de therapeutische toepassing. | |
| NL990027I1 (nl) | Bisindoolverbindingen, farmaceutische preparaten die hen bevatten en werkwijze voor hun bereiding. | |
| NL190519C (nl) | 4-Gesubstitueerde fenylazijnzuurverbindingen, alsmede farmaceutische preparaten. | |
| NL7810562A (nl) | Ureumderivaten, werkwijze ter bereiding ervan alsmede farmaceutische preparaten. | |
| NL7803626A (nl) | 2-alkyleenaminodihydropyridinen, werkwijzen ter berei- ding ervan, alsmede farmaceutische preparaten. | |
| NL7712559A (nl) | Piperidinederivaten, werkwijzen ter bereiding daarvan en farmaceutische preparaten die deze verbindingen bevatten. | |
| NL184467C (nl) | 6-oxo-prostaglandine e1 derivaten, werkwijze voor de bereiding daarvan en farmaceutische preparaten, die deze bevatten. | |
| NL7803623A (nl) | N-acetyl-dehydro-thienamycine en zouten daarvan; werk- wijze ter bereiding van deze verbindingen en farmaceu- tische preparaten. | |
| NL190285C (nl) | Werkwijze voor het bereiden van d,1-5-methyltetrahydrofoliumzuur; farmaceutisch preparaat. | |
| NL187485C (nl) | Prostaglandinederivaten, werkwijze voor de bereiding daarvan en farmaceutisch preparaat. | |
| NL7803165A (nl) | Nieuwe 7-aminothiazolylaceetamidocefalosporaan- zuuroximverbindingen, werkwijze voor hun berei- ding en farmaceutische preparaten. | |
| NL7901241A (nl) | Nieuwe gesubstitueerde 2-fenylimino-imidazolidinen, de zuuradditiezouten daarvan, farmaceutische preparaten die deze bevatten, alsmede werkwijze voor de bereiding daarvan. | |
| NL7802526A (nl) | Nieuwe 1-azaxanthonverbindingen, werkwijze ter bereiding daarvan en farmaceutische preparaten. | |
| NL187397B (nl) | Farmaceutische preparaten, 20,21-dinoreburnamenineverbindingen daarvoor en werkwijze voor hun bereiding. | |
| NL7811376A (nl) | Nieuwe imidazo-benzoxaninen en hun zouten, werkwijze voor hun bereiding en farmaceutische samenstellingen. | |
| NL190119C (nl) | Werkwijze voor de bereiding van 4-hydroxy-5-alkyl- en 4-hydroxy-2,5-dialkyl-3-oxo-2h-furanen. | |
| NL7802826A (nl) | Thienamycinederivaat, werkwijze voor het bereiden daarvan, alsmede farmaceutische preparaten. | |
| NL7902449A (nl) | 3-0-(beta-d-glucuronopyranosyl)-sojasapogenol b en zouten daarvan, farmaceutische preparaten die deze verbindingen bevatten alsmede werkwijzen voor de berei- ding van de genoemde verbindingen. | |
| NL7801921A (nl) | Farmaceutische preparaten. | |
| NL7900966A (nl) | Nieuwe 3-fenyltetrahydropyridine-derivaten en de zouten daarvan, werkwijze ter bereiding daarvan, de toepassing daarvan als geneesmiddelen en farmaceutische prepara- ten, die deze derivaten bevatten. | |
| NL190700B (nl) | Zwavelhoudende isochinolinederivaten, deze verbinding bevattende farmaceutische preparaten en werkwijze voor de bereiding van deze nieuwe verbindingen. | |
| NL7610057A (nl) | Werkwijze voor de bereiding van farmaceutische preparaten. | |
| NL7608164A (nl) | Werkwijze voor het bereiden van cefem- en penamverbindingen, alsmede werkwijze ter bereiding van farmaceutische preparaten. | |
| NL7808440A (nl) | Anti-inflammatoire 1-fenylethanolamine-derivaten, far- maceutische preparaten, die deze verbindingen bevatten en werkwijzen ter bereiding daarvan. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A85 | Still pending on 85-01-01 | ||
| BV | The patent application has lapsed |